We also show that despite the HPV positive nature of HeLa and CaSki cells (and thus low p53 activity), p53 inhibition reduces cervical cancer cell sensitivity to Cisplatin, suggesting a role for p53 in mediating Cisplatin-induced cell death. This evidence concerns the gene TP53 and cervical carcinoma.